Atara Biotherapeutics (ATRA) Amortizatization of Intangibles (2014 - 2026)
Atara Biotherapeutics (ATRA) posted Amortizatization of Intangibles of $814000.0 for Q1 2026, down 7.29% on a QoQ basis from $878000.0 in Q4 2025, and down 4.46% year-over-year from $852000.0 in Q1 2025.
Atara Biotherapeutics (ATRA) Amortizatization of Intangibles (2014 - 2026) Analysis & Trends
Atara Biotherapeutics' Amortizatization of Intangibles history runs 10 years deep, the most recent figure standing at $814000.0 for Q1 2026.
- Quarterly Amortizatization of Intangibles fell 4.46% year-over-year to $814000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 million (down 9.58% YoY) and the FY2025 annual result came in at $3.6 million, down 12.92% from the prior year.
- Amortizatization of Intangibles was $814000.0 for Q1 2026 at Atara Biotherapeutics, down from $878000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $1.3 million in Q3 2023 and bottomed at $814000.0 in Q1 2026.
- A 4-year average of $1.0 million and a median of $1.0 million in 2024 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2025 — Amortizatization of Intangibles decreased 18.55% — and 2026, when it declined 4.46%.
- Atara Biotherapeutics' Amortizatization of Intangibles stood at $1.1 million in 2023, then fell by 12.61% to $929000.0 in 2024, then retreated by 5.49% to $878000.0 in 2025, then slipped by 7.29% to $814000.0 in 2026.
- Business Quant data shows ATRA's Amortizatization of Intangibles at $814000.0 in Q1 2026, $878000.0 in Q4 2025, and $891000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 | 814,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 814,000.00 |
| Mar 31, 2026 | 814,000.00 |
| Dec 31, 2025 | 878,000.00 |
| Dec 31, 2025 | 878,000.00 |
| Sep 30, 2025 | 891,000.00 |
| Sep 30, 2025 | 891,000.00 |
| Jun 30, 2025 | 957,000.00 |
| Jun 30, 2025 | 957,000.00 |
| Mar 31, 2025 | 852,000.00 |
| Mar 31, 2025 | 852,000.00 |
| Dec 31, 2024 | 929,000.00 |
| Dec 31, 2024 | 929,000.00 |
| Sep 30, 2024 | 1.09 Mn |
| Sep 30, 2024 | 1.09 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 1.05 Mn |
| Mar 31, 2024 | 1.05 Mn |
| Dec 31, 2023 | 1.06 Mn |
| Dec 31, 2023 | 1.06 Mn |